Literature DB >> 2851728

Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells.

H W Stürzbecher1, C Addison, J R Jenkins.   

Abstract

Several mutant, but not wild-type, p53 proteins form complexes with hsp72/73 heat shock-related proteins in simian virus 40-transformed monkey COS cells. We carried out a detailed biochemical and structural mapping analysis of p53 and report here that p53-hsp72/73 complex formation showed considerable structural specificity. Such complexes were remarkably stable, but unlike analogous complexes formed between p53 and simian virus 40 T antigen, they did not form in in vitro association assays. p53-hsp72/73 complex formation in vivo appears to be dependent on aspects of mutant p53 protein conformation. However, absence of the conformation-sensitive epitope recognized by monoclonal antibody PAb 246 was not reliably diagnostic of such complexes, nor was p53-hsp72173 binding reliably diagnostic of oncogenic activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851728      PMCID: PMC365431          DOI: 10.1128/mcb.8.9.3740-3747.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53.

Authors:  J Milner; A Cook
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

3.  Speculations on the functions of the major heat shock and glucose-regulated proteins.

Authors:  H R Pelham
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

4.  Enzymatic recycling of clathrin from coated vesicles.

Authors:  J E Rothman; S L Schmid
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

5.  Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.

Authors:  T H Tan; J Wallis; A J Levine
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

6.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

7.  Specific interaction between the p53 cellular tumour antigen and major heat shock proteins.

Authors:  O Pinhasi-Kimhi; D Michalovitz; A Ben-Zeev; M Oren
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

8.  Uncoating ATPase is a member of the 70 kilodalton family of stress proteins.

Authors:  T G Chappell; W J Welch; D M Schlossman; K B Palter; M J Schlesinger; J E Rothman
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

9.  The 70-kd mammalian heat shock proteins are structurally and functionally related to the uncoating protein that releases clathrin triskelia from coated vesicles.

Authors:  E Ungewickell
Journal:  EMBO J       Date:  1985-12-16       Impact factor: 11.598

10.  Precise epitope mapping of the murine transformation-associated protein, p53.

Authors:  A Wade-Evans; J R Jenkins
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  22 in total

1.  p53 functions as a cell cycle control protein in osteosarcomas.

Authors:  L Diller; J Kassel; C E Nelson; M A Gryka; G Litwak; M Gebhardt; B Bressac; M Ozturk; S J Baker; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.

Authors:  P Würl; H Taubert; A Meye; D Berger; C Lautenschläger; H J Holzhausen; H Schmidt; H Kalthoff; F W Rath; H Dralle
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein.

Authors:  D Ginsberg; D Michael-Michalovitz; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

4.  Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.

Authors:  J Milner; E A Medcalf; A C Cook
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

Review 5.  [Stress proteins: their growing significance in medicine].

Authors:  F Fracella; L Rensing
Journal:  Naturwissenschaften       Date:  1995-07

6.  Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations.

Authors:  T D Kierstead; M J Tevethia
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.

Authors:  B I Gerwin; E Spillare; K Forrester; T A Lehman; J Kispert; J A Welsh; A M Pfeifer; J F Lechner; S J Baker; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70.

Authors:  T Soussi; C Caron de Fromentel; H W Stürzbecher; S Ullrich; J Jenkins; P May
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Conformational effects of environmentally induced, cancer-related mutations in the p53 protein.

Authors:  P W Brandt-Rauf; R Monaco; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

10.  Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression.

Authors:  P J Ridgway; T Soussi; A W Braithwaite
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.